(603880)"Jiangsu Nanfang Medical Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 603880 · · 12 pages · Chinese
Summary by 6ix AI
The report indicates a decline in revenue and net profit compared to the previous year, with significant losses reported for the quarter. It also highlights the company's total assets and shareholders' equity, showing a decrease from the previous year-end figures. The report assures the accuracy and completeness of the financial information presented, with no audit conducted for this quarter.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jiangsu Nanfang Medical Co., Ltd. on 6ix
Earlier from Jiangsu Nanfang Medical
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Release of Pledge of Certain Shares Held by Controlling Shareholder
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Pledge of Certain Shares Held by the Controlling Shareholder
- Announcement on Release of Pledge of Certain Shares Held by Persons Acting in Concert with the Controlling Shareholder
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Completion of Share Transfer Registration under Agreement by the Controlling Shareholder
Later from Jiangsu Nanfang Medical
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Financial Assistance Provided to the Company by the Controlling Shareholder and Actual Controller
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Criminal Detention of the Actual Controller
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Resignation of Director, By-election of Non-independent Directors and Appointment of Deputy General Manager
- (603880)"Jiangsu Nanfang Medical Co., Ltd."Announcement on Resolutions of the 9th Meeting of the 5th Board of Directors
Follow Jiangsu Nanfang Medical into a list and get an email when it puts out news.
Follow Jiangsu Nanfang Medical